Coya Therapeutics (COYA) Income Statement: Revenue & Earnings

Coya Therapeutics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Coya Therapeutics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	3.55	6.00	0.00	0.00	0.00
Cost of Revenue	11.87	5.50	4.41	0.00	0.00
Gross Profit	-8.31	6.00	-4.41	0.00	0.00
Operating Expenses
Research & Development	11.89	5.50	4.41	2.54	0.04
Selling, General & Administrative	8.89	7.83	4.85	2.31	0.67
Operating Expenses	8.91	13.91	9.81	4.87	0.70
Operating Income	-17.22	-7.90	-9.81	-4.87	-0.70
Other Income/Expense
Interest Income	1.65	0.64	0.00	0.00	0.00
Interest Expense	0.00	0.00	0.00	0.00	-0.06
Other Income/Expense	1.65	-0.64	-2.96	-0.02	0.00
Income
Income Before Tax	-15.60	-7.26	-12.24	-4.89	-1.10
Income Tax Expense	-0.72	0.72	0.00	0.00	0.00
Net Income	-14.88	-7.99	-12.24	-4.89	-1.10
Net Income - Continuous Operations	-14.88	-7.99	-12.24	-4.89	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-17.20	-7.24	-9.26	-4.85	0.00
EBIT	-17.22	-7.26	-9.29	-4.87	-0.70
Depreciation & Amortization	0.03	0.03	0.03	0.02	0.00
Earnings Per Share
Basic EPS	-1.00	-1.00	-5.00	-2.00	-1.00
Diluted EPS	-1.00	-1.00	-5.00	-2.00	-1.00
Basic Shares Outstanding	15.24	10.16	2.59	2.59	1.84
Diluted Shares Outstanding	15.24	10.16	2.59	2.59	1.84